An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K. regulators cleared Sarepta to restart an Elevidys study and Altos Labs ...

Leaders must re-examine the healthcare supply network and shift the focus from cost savings to building resilience—all while ...

Three years ago, as the pandemic caused chaos for companies big and small, Colgate-Palmolive’s chief supply chain officer ...